AI assistant
HAEMONETICS CORP — Director's Dealing 2010
Oct 29, 2010
31565_dirs_2010-10-29_8d938674-773a-438c-a55a-3e3e50220bb3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2010-10-27
Reporting Person: HANLON SUSAN M (VP Finance)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-10-27 | Common Stock | A | 1287.0000 | $0.0100 | Acquired | 6567.0000 | Direct |
| 2010-10-28 | Common Stock | D | 72.0000 | $55.1900 | Disposed | 6495.0000 | Direct |
| 2010-10-28 | Common Stock | D | 71.0000 | $55.1900 | Disposed | 6424.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-10-27 | Non-Qualified Stock Option (right to buy) | $54.9900 | A | 11174.0000 | Acquired | 2017-10-27 | Common Stock (11174) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $26.1050 | 2014-05-05 | Common Stock (5000) | 5000.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $30.3850 | 2012-05-28 | Common Stock (9500) | 9500.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $41.1500 | 2012-07-27 | Common Stock (5000) | 5000.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $51.0700 | 2014-10-24 | Common Stock (3569) | 3569.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $52.7600 | 2013-05-05 | Common Stock (7282) | 7282.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $52.9400 | 2016-10-27 | Common Stock (7345) | 7345.0000 | Direct |
| Non-Qualified Stock Option (right to buy) | $54.5500 | 2015-10-22 | Common Stock (3603) | 3603.0000 | Direct |
Footnotes
F1: Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.
F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
F3: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.
F4: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.